Skip to content
by Legal Desire
23 October 2025

Baker McKenzie Advises Takeda in Global Strategic Partnership with Innovent Biologics

Advising firms

Deal team

8 lawyers named
LawyerFirmSeniorityPracticeOffice
Randy Sunberg Baker McKenzie Partner licensing, option and collaboration agreement New York
Devin Muntz Baker McKenzie Associate licensing, option and collaboration agreement Chicago
Anat Polyachenko Baker McKenzie Associate licensing, option and collaboration agreement New York
Julia Rossié Baker McKenzie Associate licensing, option and collaboration agreement Munich
Christina Lee Baker McKenzie Partner share issuance agreement Hong Kong
Brian Wong Baker McKenzie Partner share issuance agreement Hong Kong
Creighton Macy Baker McKenzie Partner HSR/antitrust matters Washington, DC
Daniel Duk-ki Moon Baker McKenzie Associate HSR/antitrust matters Washington, DC

5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 1.20bn (USD 1.2 billion)
What the figure measures
Total transaction value
Client
TakedaJoint venture party
Counterparties
Innovent Biologics (Joint venture party)